Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization

被引：0
|
作者：
Renaud Sabatier
Pascal Finetti
Arnaud Guille
José Adelaide
Max Chaffanet
Patrice Viens
Daniel Birnbaum
François Bertucci
机构：
[1] Institut Paoli-Calmettes (IPC),Department of Molecular Oncology, Centre de Recherche en Cancérologie de Marseille, UMR1068 Inserm
[2] Institut Paoli-Calmettes (IPC),Department of Medical Oncology
[3] Université Aix-Marseille,Faculté de Médecine
来源：
Molecular Cancer | / 13卷
关键词：
Breast cancer; Claudin-low; Molecular profiling; Prognosis; Response to chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Branched chain amino acid transaminase 1 in claudin-low breast cancer
    Reynen, Lisa C.
    Jones, Robert
    Moorehead, Roger
    CANCER RESEARCH, 2019, 79 (13)
  • [32] DPYSL3 modulates proliferation and migration in claudin-low breast cancer
    Matsunuma, Ryoichi
    Chan, Doug W.
    Kim, Beom-Jun
    Singh, Purba
    Han, Airi
    Malovannaya, Anna
    Perou, Charles M.
    Ellis, Matthew J.
    CANCER RESEARCH, 2018, 78 (04)
  • [33] Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells
    Radler, Patrick D.
    Wehde, Barbara L.
    Triplett, Aleata A.
    Shrestha, Hridaya
    Shepherd, Jonathan H.
    Pfefferle, Adam D.
    Rui, Hallgeir
    Cardiff, Robert D.
    Perou, Charles M.
    Wagner, Kay-Uwe
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [34] Computational Image Analysis To Identify a Morphological Signature of Claudin-Low Breast Cancer
    Singh, K.
    Collins, L.
    Knobouch, N.
    Hefti, M.
    Beck, A.
    LABORATORY INVESTIGATION, 2013, 93 : 69A - 70A
  • [35] High SLC20A1 Expression Is Associated With Poor Prognoses in Claudin-low and Basal-like Breast Cancers
    Onaga, Chotaro
    Tamori, Shoma
    Motomura, Hitomi
    Ozaki, Ayaka
    Matsuda, Chika
    Matsuoka, Izumi
    Fujita, Takuma
    Nozaki, Yuka
    Hara, Yasushi
    Kawano, Yohei
    Harada, Yohsuke
    Sato, Tsugumichi
    Mano, Yasunari
    Sato, Keiko
    Akimoto, Kazunori
    ANTICANCER RESEARCH, 2021, 41 (01) : 43 - 54
  • [36] Synergistic effect of pyrazoles derivatives and doxorubicin in claudin-low breast cancer subtype
    Saueressig, Silvia
    Tessmann, Josiane
    Mastelari, Rosiane
    da Silva, Liziane Pereira
    Buss, Julieti
    Segatto, Natalia Vieira
    Begnini, Karine Rech
    Pacheco, Bruna
    Pereira de Pereira, Claudio Martin
    Collares, Tiago
    Seixas, Fabiana Kommling
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 : 390 - 398
  • [37] Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells
    Patrick D. Rädler
    Barbara L. Wehde
    Aleata A. Triplett
    Hridaya Shrestha
    Jonathan H. Shepherd
    Adam D. Pfefferle
    Hallgeir Rui
    Robert D. Cardiff
    Charles M. Perou
    Kay-Uwe Wagner
    Nature Communications, 12
  • [38] Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype
    Rito, Miguel
    Schmitt, Fernando
    Pinto, Antonio E.
    Andre, Saudade
    VIRCHOWS ARCHIV, 2014, 465 (02) : 185 - 191
  • [39] Inhibition of proliferation and migration of luminal and claudin-low breast cancer cells by PDGFR inhibitors
    Stalker, Leanne
    Pemberton, James
    Moorehead, Roger A.
    CANCER CELL INTERNATIONAL, 2014, 14
  • [40] Glycoproteins in Claudin-Low Breast Cancer Cell Lines Have a Unique Expression Profile
    Yen, Ten-Yang
    Bowen, Spencer
    Yen, Roger
    Piryatinska, Alexandra
    Macher, Bruce A.
    Timpe, Leslie C.
    JOURNAL OF PROTEOME RESEARCH, 2017, 16 (04) : 1391 - 1400
12345